Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel Free ADPT Stock Alerts

Adaptive Biotechnologies (ADPT) Short Interest Ratio & Short Volume

Adaptive Biotechnologies logo
$22.27 -0.04 (-0.18%)
Closing price 07/24/2026 04:00 PM Eastern
Extended Trading
$22.43 +0.16 (+0.73%)
As of 07/24/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Adaptive Biotechnologies Short Interest Overview

As of July 15, 2026, Adaptive Biotechnologies (ADPT) had a short interest of 11.40 million shares sold short, representing 7.55% of the public float. This marks a 0.38% increase in short interest since the prior report. The short interest ratio (days to cover) is 4.3, meaning it would take 4.3 days of the average trading volume of 2.83 million shares to cover all short positions.

Current Short Interest
11,396,387 shares
Previous Short Interest
11,352,839 shares
Change Vs. Previous Month
0.38%
Dollar Volume Sold Short
$260.98 million
Short Interest Ratio
4.3 Days to Cover
Last Record Date
July 15, 2026
Outstanding Shares
160,040,000 shares
Short Percent of Float
7.55%
Today's Trading Volume
2,819,935 shares
Average Trading Volume
2,832,934 shares
Today's Volume Vs. Average
100%
Short Selling Adaptive Biotechnologies?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Adaptive Biotechnologies and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ADPT Short Interest Over Time

ADPT Days to Cover Over Time

ADPT Percentage of Float Shorted Over Time

Adaptive Biotechnologies Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/202611,396,387 shares $260.98 million +0.4%7.6%4.31 $22.90
6/30/202611,352,839 shares $243.52 million +48.5%7.5%2.23 $21.45
6/15/20267,645,147 shares $133.48 million -7.2%5.1%2.82 $17.46
5/29/20268,240,744 shares $124.85 million -7.4%5.5%5.13 $15.15
5/15/20268,897,341 shares $114.15 million +5.4%5.9%4.55 $12.83
4/30/20268,439,712 shares $119.00 million -1.3%5.6%6.94 $14.10
4/15/20268,551,420 shares $124.25 million -0.1%5.7%4.41 $14.53
3/31/20268,558,955 shares $118.80 million -7.4%5.7%4.06 $13.88
3/13/20269,247,322 shares $121.79 million +4.2%6.4%3.65 $13.17
2/27/20268,877,604 shares $142.22 million -3.4%5.9%6.51 $16.02
2/13/20269,193,089 shares $147.46 million +1.8%6.1%4.27 $16.04
1/30/20269,033,105 shares $167.11 million +0.1%6.3%5.56 $18.50
1/15/20269,021,329 shares $160.40 million +3.0%6.3%4.01 $17.78
12/31/20258,760,209 shares $142.27 million -10.1%6.1%4.43 $16.24
12/15/20259,742,510 shares $152.86 million -6.4%6.8%2.94 $15.69
11/28/202510,403,303 shares $163.23 million +0.3%7.3%3.75 $15.69
11/14/202510,368,382 shares $146.19 million +15.1%7.3%4.98 $14.10
10/31/20259,010,315 shares $156.42 million -0.2%6.3%5.84 $17.36
10/15/20259,030,000 shares $154.50 million -5.8%6.3%4.6 $17.11
9/30/20259,590,000 shares $143.47 million +2.7%N/A4.8 $14.96
9/15/20259,340,000 shares $122.17 million +10.8%N/A4.4 $13.08
8/31/20258,430,000 shares $111.11 million -5.8%5.9%4.1 $13.18
8/15/20258,950,000 shares $116.71 million -9.9%N/A4.5 $13.04
7/31/20259,930,000 shares $101.68 million +2.5%7.0%5.3 $10.24
7/15/20259,690,000 shares $107.17 million -4.3%N/A4.5 $11.06
6/30/202510,130,000 shares $118.01 million +13.4%7.1%4.5 $11.65
6/15/20258,930,000 shares $92.16 million -7.4%6.3%4.2 $10.32
5/31/20259,640,000 shares $91.77 million +5.9%7.0%4.4 $9.52
5/15/20259,100,000 shares $81.08 million -0.4%6.6%4 $8.91
4/30/20259,140,000 shares $67.27 million -7.6%N/A3.8 $7.36
4/15/20259,890,000 shares $76.55 million -2.3%7.1%5.1 $7.74
3/31/202510,120,000 shares $75.19 million +6.6%7.3%5.2 $7.43
3/15/20259,490,000 shares $69.09 million +9.6%6.9%5.8 $7.28
2/28/20258,660,000 shares $71.53 million -1.4%6.3%5.8 $8.26
2/15/20258,780,000 shares $73.14 million +2.9%6.3%6 $8.33
1/31/20258,530,000 shares $66.11 million -1.5%N/A6.1 $7.75
1/15/20258,660,000 shares $62.01 million -5.8%N/A6.5 $7.16
12/31/20249,190,000 shares $55.05 million +1.8%N/A7.7 $5.99
12/15/20249,030,000 shares $56.89 million -5.7%N/A7.3 $6.30
11/30/20249,580,000 shares $56.91 million +16.8%N/A8.1 $5.94
Ready to give options a try? Your first trade (Ticker included) -INSIDE (Ad)

Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel

11/15/20248,200,000 shares $41.66 million -8.5%N/A7.2 $5.08
10/31/20248,960,000 shares $43.37 million -5.5%N/A8.5 $4.84
10/15/20249,480,000 shares $47.12 million -4.3%N/A8.2 $4.97
9/30/20249,910,000 shares $50.74 million +2.9%N/A8.1 $5.12
9/15/20249,630,000 shares $44.39 million -0.8%N/A7.6 $4.61
8/31/20249,710,000 shares $45.64 million +0.5%N/A7.4 $4.70
8/15/20249,660,000 shares $47.62 million -11.8%N/A6.6 $4.93
7/31/202410,950,000 shares $49.82 million -8.1%N/A7.3 $4.55
7/15/202411,910,000 shares $48.00 million -1.9%N/A7.9 $4.03
6/30/202412,140,000 shares $43.95 million -7.0%N/A7.4 $3.62
6/15/202413,050,000 shares $40.85 million -2.5%N/A7.6 $3.13
5/31/202413,380,000 shares $46.16 million +1.8%N/A7.8 $3.45
5/15/202413,140,000 shares $51.25 million +9.1%N/A7.9 $3.90
4/30/202412,040,000 shares $31.54 million +20.3%N/A7 $2.62
4/15/202410,010,000 shares $29.13 million +10.0%7.2%6 $2.91
3/31/20249,100,000 shares $29.21 million +7.6%6.6%6.1 $3.21
3/15/20248,460,000 shares $27.41 million -3.5%6.1%5.9 $3.24
2/29/20248,770,000 shares $36.04 million -4.6%N/A5.9 $4.11
2/15/20249,190,000 shares $36.39 million +4.3%N/A6.6 $3.96
1/31/20248,810,000 shares $32.33 million +0.6%N/A5.9 $3.67
1/15/20248,760,000 shares $38.54 million -7.4%N/A5.6 $4.40
12/31/20239,460,000 shares $46.35 million -1.3%N/A6.3 $4.90
12/15/20239,580,000 shares $46.65 million -8.7%N/A6 $4.87
11/30/202310,490,000 shares $45.95 million -6.6%N/A6.8 $4.38
11/15/202311,230,000 shares $48.06 million +4.6%N/A7.3 $4.28
10/31/202310,740,000 shares $47.69 million +8.5%N/A7.7 $4.44
10/15/20239,900,000 shares $42.42 million -6.9%N/A7.4 $4.29
9/30/202310,630,000 shares $57.93 million +7.6%N/A8.1 $5.45
9/15/20239,880,000 shares $59.87 million -5.1%N/A8.4 $6.06
8/31/202310,410,000 shares $70.48 million +3.5%N/A9.1 $6.77
8/15/202310,060,000 shares $63.28 million +5.3%N/A8.7 $6.29
7/31/20239,550,000 shares $80.60 million +6.4%N/A8.8 $8.44
7/15/20238,980,000 shares $64.39 million +12.1%N/A8.9 $7.17
6/30/20238,010,000 shares $53.75 million -0.9%5.8%7.9 $6.71
6/15/20238,080,000 shares $70.05 million +10.4%5.8%8.2 $8.67
5/31/20237,320,000 shares $50.95 million +10.4%5.3%8.2 $6.96
5/15/20236,630,000 shares $43.03 million +8.9%4.8%7.7 $6.49
4/30/20236,090,000 shares $43.48 million +12.2%4.4%6.7 $7.14
4/15/20235,430,000 shares $42.95 million -11.3%3.9%5.9 $7.91
3/31/20236,120,000 shares $54.04 million +14.8%4.4%6.4 $8.83
3/15/20235,330,000 shares $43.81 million +9.5%3.9%5.3 $8.22
2/28/20234,870,000 shares $41.64 million +9.4%3.5%4.9 $8.55
2/15/20234,450,000 shares $44.63 million -6.3%3.2%4.4 $10.03
1/31/20234,750,000 shares $44.03 million -12.4%3.4%4.7 $9.27
1/15/20235,420,000 shares $53.87 million -8.3%3.9%5.2 $9.94
12/30/20225,910,000 shares $45.15 million +25.0%4.2%5.8 $7.64
12/15/20224,730,000 shares $38.45 million -11.1%3.4%4.7 $8.13
11/30/20225,320,000 shares $46.71 million +3.3%3.8%5.2 $8.78
11/15/20225,150,000 shares $46.81 million -13.9%3.7%4.9 $9.09
10/31/20225,980,000 shares $46.52 million -2.3%4.3%5.4 $7.78
Your book attached (Ad)

Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel

Download the Safe Trade Options Formula book for free before access closes
10/15/20226,120,000 shares $38.31 million -5.1%4.4%5.4 $6.26
9/30/20226,450,000 shares $45.92 million +3.4%4.6%5.7 $7.12
9/15/20226,240,000 shares $52.67 million -9.4%4.5%4.4 $8.44
8/31/20226,890,000 shares $61.46 million +6.0%4.9%4.4 $8.92
8/15/20226,500,000 shares $82.36 million +1.3%4.7%3.9 $12.67
7/31/20226,420,000 shares $58.81 million -7.6%4.6%3.7 $9.16
7/15/20226,950,000 shares $66.23 million -7.6%5.0%3.9 $9.53
6/30/20227,520,000 shares $60.84 million +2.7%5.4%4.1 $8.09
6/15/20227,320,000 shares $52.34 million +15.5%5.3%4.2 $7.15
5/31/20226,340,000 shares $49.58 million -8.3%4.6%4.4 $7.82
5/15/20226,910,000 shares $56.94 million +32.4%5.0%4.8 $8.24
4/30/20225,220,000 shares $43.07 million -1.9%3.8%3.8 $8.25
4/15/20225,320,000 shares $57.56 million +11.5%3.8%4.1 $10.82
3/31/20224,770,000 shares $66.21 million -12.0%N/A3.8 $13.88
3/15/20225,420,000 shares $58.27 million -0.4%N/A4.5 $10.75
2/28/20225,440,000 shares $78.50 million -5.2%3.9%4.9 $14.43
2/15/20225,740,000 shares $84.32 million +10.0%4.1%5.1 $14.69
1/31/20225,220,000 shares $91.04 million +20.3%3.8%5.3 $17.44
1/15/20224,340,000 shares $83.98 million +14.2%3.1%5 $19.35
12/31/20213,800,000 shares $106.63 million -6.6%2.7%5.1 $28.06
12/15/20214,070,000 shares $111.03 million +8.8%2.9%5.9 $27.28
11/30/20213,740,000 shares $97.58 million -0.8%2.7%5.7 $26.09
11/15/20213,770,000 shares $122.83 million -10.9%2.7%6.3 $32.58
10/29/20214,230,000 shares $141.32 million -0.9%3.0%7.7 $33.41
10/15/20214,270,000 shares $143.05 million -3.2%3.1%8 $33.50
9/30/20214,410,000 shares $149.90 million +4.8%3.2%7.9 $33.99
9/15/20214,210,000 shares $154.13 million +5.3%3.0%7.1 $36.61
8/31/20214,000,000 shares $145.28 million -8.5%2.9%6.8 $36.32
8/13/20214,370,000 shares $138.97 million -8.0%3.2%7.1 $31.80
7/30/20214,750,000 shares $174.14 million +3.9%3.4%6.5 $36.66

ADPT Short Interest - Frequently Asked Questions

Short interest is the volume of Adaptive Biotechnologies shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 11,396,387 shares of ADPT short. 7.55% of Adaptive Biotechnologies' shares are currently sold short. Learn More on Adaptive Biotechnologies' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ADPT shares currently have a short interest ratio of 4.3. Learn More on Adaptive Biotechnologies's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.55% of Adaptive Biotechnologies' floating shares are currently sold short.

Adaptive Biotechnologies saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 11,396,387 shares, an increase of 0.4% from the previous total of 11,352,839 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

7.55% of Adaptive Biotechnologies' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Adaptive Biotechnologies: Elanco Animal Health Incorporated (7.25%), Abivax SA Sponsored ADR (4.61%), Axsome Therapeutics, Inc. (7.40%), Summit Therapeutics PLC (29.15%), Dr. Reddy's Laboratories Ltd (2.56%), Arrowhead Pharmaceuticals, Inc. (7.10%), Krystal Biotech, Inc. (13.65%), Cytokinetics, Incorporated (14.07%), Nuvalent, Inc. (0.95%), Kymera Therapeutics, Inc. (14.33%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($73.09 billion), Invesco QQQ ($48.11 billion), iShares Russell 2000 ETF ($23.61 billion), Sandisk Corporation ($12.69 billion), Nebius Group N.V. ($12.18 billion), Western Digital Corporation ($11.95 billion), SPDR S&P Biotech ETF ($11.73 billion), Quhuo Limited Sponsored ADR ($9.74 billion), VanEck Semiconductor ETF ($9.57 billion), and Financial Select Sector SPDR Fund ($8.43 billion). View all of the most shorted stocks.

Short selling ADPT is an investing strategy that aims to generate trading profit from Adaptive Biotechnologies as its price is falling. ADPT shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Adaptive Biotechnologies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ADPT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADPT, twice per month. The most recent reporting period available is July, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ADPT:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:ADPT) was last updated on 7/24/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel